Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
The objective of this study was to investigate the current situation of vancomycin
 (VAN)-associated acute kidney injury (VA-AKI) in China and identify the risk factors for
 VA-AKI, as well as to comprehensively examine the risk related to concurrent drug use.
 Further, the investigators assessed the outcomes of patients who developed VA-AKI and the
 risk factors for these outcomes. Finally, the investigators aimed to provide suggestions for
 improving the prevention and treatment of VA-AKI in China.
Inclusion Criteria:

 -  Using Vancomycin

 -  ≥18 years old

 Exclusion Criteria:

 -  Medical records were incomplete

 -  Had been diagnosed with stage 5 CKD or were regularly receiving dialysis

 -  SCr were not being adequately monitored to detect the development of AKI

 -  Had undergone nephrectomy